Article

Predicting response to disease modifying treatment in multiple sclerosis

2018-01-01

Abstract excerpt

Multiple sclerosis (MS) is an autoimmune disease affecting the central nervous system (CNS) that most commonly begins with a relapsing-remitting course (RRMS). Many disease modifying treatments now are available, but none have efficacy in all patients, all are expensive and all are associated with possible adverse events. Stratifying patients to the best tolerated and most efficacious treatment either prior to or...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e39727a3-bc7a-514f-ad4b-2574c6516cbd
DOI: 10.25560/56612

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Predicting response to disease modifying treatment in multiple sclerosisDOI 10.25560/56612Read

Omics approaches to understanding the efficacy and safety of disease-modifying treatments in multiple sclerosisSemantic proximity Read

Pharmacogenomics and multiple sclerosis: moving toward individualized medicine.Semantic proximity Read

United Europeans for development of pharmacogenomics in multiple sclerosis network.Semantic proximity Read

Plasma microRNA Signature as Predictive Marker of Clinical Response to Therapy During Multiple SclerosisSemantic proximity Read

Current status and future opportunities in modeling Multiple Sclerosis clinical characteristicsSemantic proximity Read

Application of pharmacogenomics to investigate adverse drug reactions to the disease-modifying treatments for multiple sclerosis: a case-control study protocol for dimethyl fumarate-induced lymphopenia.Semantic proximity Read

Pharmacogenetics of multiple sclerosisSemantic proximity Read

Implications for multiple sclerosis in the era of the Affordable Care Act: an evolving treatment paradigm.Semantic proximity Read

Interferon beta treatment is a potent and targeted epigenetic modifier in multiple sclerosisSemantic proximity Read

Real-world Safety and Efficacy of Dimethyl Fumarate in Relapse-Remitting Multiple Sclerosis Patients: A Regional Cohort Report of the Iranian PatientsSemantic proximity Read

Predicting personalised risk of disability worsening in multiple sclerosis with machine learningSemantic proximity Read

Multiple sclerosis diagnosis and phenotype identification by multivariate classification of in vivo frontal cortex metabolite profiles.Semantic proximity Read